BDNF has a neuroprotective role against the pathogenesis of AD by reducing the expression and the activity of β-secretase, thereby inhibiting the amyloidogenic pathway and reducing neurotoxic Aβ formation in transgenic mice (Evans et al., 2011). This evidence concerns the gene BDNF and Alzheimer disease.